Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Phleum pratense immunotherapy for grass pollen hypersensitivity
2004-001966-41Phase 4Active
- Sponsor
- LETI Pharma
- Start
- Nov 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of allergovac depot in allergic rhinitis (AR), allergic conjunctivitis (AC) and asthma (2 arms), sponsored by LETI Pharma. Primary endpoint: Total symptom score. Started Nov 2004; status: active.
02
Drugs
allergovac depot
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)asthma
Beyond the preview
Go deeper on 2004-001966-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001966-41.